SEROLOGICAL RESPONSES AFTER SARS‐COV‐2 VACCINATION FIRST DOSE IN PATIENTS WITH LYMPHOID MALIGNANCY: FIRST INTERIM ANALYSIS OF THE UK PROSECO STUDY
| Autor: | Graham P. Collins, C. Mundy, P. Johnson, B. Maynard, A. Bates, David Goldblatt, H. Coleman, Matthew J. Ahearne, S. N. Faust, R. Lown, J. Falconer, Mark H. Johnson, Debora Joseph-Pietras, V. Willimott, Ann O'Callaghan, D. Muller, N. Wetherall, N. Campbell, Andrew Davies, T. Wynn, Christopher P. Fox, Sean H. Lim |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Cancer Research
2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Hematology General Medicine Interim analysis Virology Serology Vaccination E‐posters Oncology Lymphoid malignancy Medicine In patient SUPPLEMENT: 16th INTERNATIONAL CONFERENCE ON MALIGNANT LYMPHOMA VIRTUAL EDITION 18–22 JUNE 2021 Supplement Abstract business |
| Zdroj: | Hematological Oncology |
| ISSN: | 1099-1069 0278-0232 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text